Smoking and depression: a qualitative study.
Research type
Research Study
Full title
ESCAPE: Perspectives on smoking cessation treatment offered alongside routine psychological care for depression - a qualitative study
IRAS ID
225399
Contact name
Gemma Taylor
Contact email
Sponsor organisation
The University of Bristol
Clinicaltrials.gov Identifier
RC000648, University of Bristol company number; C56067/A21330, CRUK Funding Reference number
Duration of Study in the UK
1 years, 0 months, 0 days
Research summary
Tobacco is the world’s leading cause of disease and death. In the United Kingdom and in western nations smoking prevalence has declined significantly in the general population, but has not changed much in people with mental health disorders, resulting in high rates of smoking-related disease and death in this group. People with depression are twice as likely to smoke, they are more heavily addicted to cigarettes, and are less responsive to usual tobacco treatments compared to people without depression. Because of these inequalities there is a need for treatments that target both mental and physical health. In England, people with depression have access to NHS therapy, known as ‘Improving Access to Psychological Therapies’ or IAPT, for short. IAPT may be an ideal platform for offering people with depression smoking cessation treatment. Therefore, in this study we will conduct interviews with IAPT service users, therapists and smoking cessation advisors to explore their views about 1) smoking and depression, 2) parallel treatment of tobacco addiction and depression, and 3) to collect information to inform future research.
REC name
West Midlands - Black Country Research Ethics Committee
REC reference
17/WM/0251
Date of REC Opinion
13 Jul 2017
REC opinion
Further Information Favourable Opinion